NIH Study Finds Protein May be Responsible for Damage in Eosinophilic Esophagitis
Findings Present a Potential Drug Target
Thursday, April 07, 2016
Scientists have identified a protein that may be the cause of tissue damage in patients with eosinophilic esophagitis (EoE), which affects as many as 56 of every 100,000 people in the United States. EoE is a food allergy-related disease in which white blood cells called eosinophils accumulate in the esophagus, often causing difficult or painful swallowing, nausea, vomiting and poor growth in children and adults. Further understanding of the role of this protein, calpain 14, may lead to potential therapies for EoE. The researchers received support from the National Institute of Allergy and Infectious Diseases and the National Institute of Diabetes and Digestive and Kidney Diseases, both part of the National Institutes of Health.
Researchers from the Cincinnati Children’s Hospital Medical Center, led by Marc E. Rothenberg, MD, PhD, had previously identified genetic differences in EoE patients that led them to focus on the CAPN14 gene, which codes for calpain 14. In this new study, the research team collected esophageal biopsies from patients with EoE to identify a possible role for calpain 14 in the disease. They exposed cells from these tissues to an immune system signaling protein called interleukin-13, which is produced during allergic reactions, mimicking signals that may contribute to EoE in the body.
The researchers found that interleukin-13 caused cells from patients with EoE to increase markedly production of calpain 14. They also found that calpain 14 in esophageal epithelial cells regulates another protein called desmoglein 1, a critical component of tissue in the esophagus, and that these molecular changes may be an early step in a process that leads to inflammation and scarring in the esophagus. The findings suggest that controlling the production or activity of calpain 14 may prevent the development of EoE. In this regard, calpain 14 may be a valuable drug target for further research, the researchers note.
M Rothenberg et al. Eosinophilic Esophagitis-linked Calpain 14 is an IL-13-induced Protease that Mediates Esophageal Epithelial Barrier Impairment. JCI Insight DOI: 10.1172/jci.insight.86355 (2016).
Marshall Plaut, M.D., chief of the Food Allergy, Atopic Dermatitis and Allergic Mechanisms Section in NIAID’s Division of Allergy, Immunology and Transplantation, is available to discuss the findings.
NIAID conducts and supports research—at NIH, throughout the United States, and worldwide—to study the causes of infectious and immune-mediated diseases, and to develop better means of preventing, diagnosing and treating these illnesses. News releases, fact sheets and other NIAID-related materials are available on the NIAID website.
About the National Institutes of Health (NIH)
NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. Learn more about NIH and its programs.
NIH...Turning Discovery Into Health®
National Institute of Allergy and
Infectious Diseases (NIAID)
About Cincinnati Children's
Cincinnati Children’s Hospital Medical Center ranks third in the nation among all Honor Roll hospitals in U.S. News & World Report’s 2015 Best Children’s Hospitals. It is also ranked in the top 10 for all 10 pediatric specialties, including a #1 ranking in pulmonology and #2 in cancer and in nephrology. Cincinnati Children’s, a non-profit organization, is one of the top three recipients of pediatric research grants from the National Institutes of Health, and a research and teaching affiliate of the University of Cincinnati College of Medicine. The medical center is internationally recognized for improving child health and transforming delivery of care through fully integrated, globally recognized research, education and innovation. Additional information can be found at www.cincinnatichildrens.org. Connect on the Cincinnati Children’s blog, via Facebook and on Twitter.